93 related articles for article (PubMed ID: 21444105)
21. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
22. Pelvic Exenteration Put into Therapeutical and Palliative Perspective: It Is Worth to Try.
Karmaniolou I; Arkadopoulos N; Vassiliou P; Nastos C; Dellaportas D; Siatelis A; Theodosopoulos T; Vezakis A; Parasyris S; Polydorou A; Smyrniotis V
Indian J Surg Oncol; 2018 Dec; 9(4):552-557. PubMed ID: 30538387
[TBL] [Abstract][Full Text] [Related]
23. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
24. Pelvic Exenteration for Recurrent and Persistent Cervical Cancer.
Li L; Ma SQ; Tan XJ; Zhong S; Wu M
Chin Med J (Engl); 2018 Jul; 131(13):1541-1548. PubMed ID: 29941707
[TBL] [Abstract][Full Text] [Related]
25. Abdominoperineal Excisions in the Treatment Regimen for Advanced and Recurrent Vulvar Cancers-Analysis of a Single-Centre Experience.
Hannes S; Nijboer JM; Reinisch A; Bechstein WO; Habbe N
Indian J Surg; 2015 Dec; 77(Suppl 3):1270-4. PubMed ID: 27011549
[TBL] [Abstract][Full Text] [Related]
26. Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.
Stabile C; Gunn A; Sonoda Y; Carter J
Transl Androl Urol; 2015 Apr; 4(2):169-85. PubMed ID: 26816823
[TBL] [Abstract][Full Text] [Related]
27. Pelvic exenteration: experience from a rural cancer center in developing world.
Dessai SB; Balasubramanian S; Patil VM; Chakraborty S; Bhattacharjee A; Vikram S
Int J Surg Oncol; 2015; 2015():729658. PubMed ID: 25741445
[TBL] [Abstract][Full Text] [Related]
28. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of a bladder preservation technique in female patients undergoing pelvic exenteration surgery for advanced gynaecological tumours.
Liedl B; Khoder WY; Ruhdorfer-Metz B; Stief CG; Waidelich R
Int Urogynecol J; 2014 Jul; 25(7):953-60. PubMed ID: 24633066
[TBL] [Abstract][Full Text] [Related]
30. Pelvic exenteration: impact of age on surgical and oncologic outcomes.
Huang M; Iglesias DA; Westin SN; Fellman B; Urbauer D; Schmeler KM; Frumovitz M; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Jan; 132(1):114-8. PubMed ID: 24262877
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer.
Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Klein KA; Haddock MG
Radiat Oncol; 2013 Apr; 8():80. PubMed ID: 23566444
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
33. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.
Yoo HJ; Lim MC; Seo SS; Kang S; Yoo CW; Kim JY; Park SY
J Gynecol Oncol; 2012 Oct; 23(4):242-50. PubMed ID: 23094127
[TBL] [Abstract][Full Text] [Related]
34. Total pelvic exenteration for gynecologic malignancies.
Diver EJ; Rauh-Hain JA; Del Carmen MG
Int J Surg Oncol; 2012; 2012():693535. PubMed ID: 22720150
[TBL] [Abstract][Full Text] [Related]
35. The effect of body mass index on surgical outcomes and survival following pelvic exenteration.
Iglesias DA; Westin SN; Rallapalli V; Huang M; Fellman B; Urbauer D; Frumovitz M; Ramirez PT; Soliman PT
Gynecol Oncol; 2012 May; 125(2):336-42. PubMed ID: 22261299
[TBL] [Abstract][Full Text] [Related]
36. Contemporary quality of life issues affecting gynecologic cancer survivors.
Carter J; Penson R; Barakat R; Wenzel L
Hematol Oncol Clin North Am; 2012 Feb; 26(1):169-94. PubMed ID: 22244668
[TBL] [Abstract][Full Text] [Related]
37. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.
Benn T; Brooks RA; Zhang Q; Powell MA; Thaker PH; Mutch DG; Zighelboim I
Gynecol Oncol; 2011 Jul; 122(1):14-8. PubMed ID: 21444105
[TBL] [Abstract][Full Text] [Related]
38. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
[TBL] [Abstract][Full Text] [Related]
39. Overall survival after pelvic exenteration for gynecologic malignancy.
Westin SN; Rallapalli V; Fellman B; Urbauer DL; Pal N; Frumovitz MM; Ramondetta LM; Bodurka DC; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Sep; 134(3):546-51. PubMed ID: 25014540
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
